Danilo Tagle is Director, Office of Special Initiatives at the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) where he leads efforts in developing innovative tools and technologies that can greatly accelerate development of diagnostics and therapeutics. These programs involve interdisciplinary collaborations between intramural and extramural components of NIH, and entail partnerships with other agencies, such as FDA, NASA and DARPA, as well as with private sector. Some of the programs include tissue chips, 3D bioprinting, automated chemistry, electronic nose technology for disease diagnosis, and the isolation and analyses of exosomes for biomarker and therapy development. He has served on numerous advisory and review committees and editorial boards. He currently serves on the NASA Biological and Physical Sciences Federal Advisory Committee, on the White House OSTP Microgravity Science and Technology Interagency Working Group and serves as the point-of-contact for the liaison to the NASA/NIH/Department of Health and Human Services partnership.